Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why diabetes and weight loss drugs work better than alcohol medications.
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...
Eli Lilly and Co. (LLY) has released detailed findings from the Phase 3 SUMMIT trial, demonstrating that tirzepatide significantly ...
HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...
A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback